Rhinitis, Allergic, Perennial and Seasonal Clinical Trial
Official title:
Drug Use Investigation for XYZAL
This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.
n/a
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02424539 -
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
|
Phase 4 | |
Completed |
NCT01949051 -
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
|
Phase 2 | |
Completed |
NCT01957202 -
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
|
Phase 2 | |
Completed |
NCT01962467 -
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
|
Phase 1 | |
Completed |
NCT01001130 -
Regulatory AVAMYS Nasal Spray PMS
|
N/A | |
Completed |
NCT01622283 -
Pharmacokinetic Study of Levocetirizine Oral Solution
|
Phase 1 | |
Completed |
NCT02397915 -
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
|
Phase 4 | |
Completed |
NCT01916226 -
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
|
Phase 4 | |
Completed |
NCT00109486 -
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
|
Phase 3 |